⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IVVD News
Invivyd, Inc. Common Stock
Invivyd Announces Selection of Potential Best-In-Class RSV Antibody Candidate VBY329; Targeting 2H 2026 IND Readiness
globenewswire.com
IVVD
Invivyd Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants
globenewswire.com
IVVD
Invivyd Announces Proposed Public Offering of Common Stock
globenewswire.com
IVVD
Invivyd Reports Third Quarter 2025 Financial Results and Recent Business Highlights
globenewswire.com
IVVD
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
globenewswire.com
IVVD
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
globenewswire.com
IVVD
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
globenewswire.com
IVVD